Physical dependence on clonazepam in dogs

Area of Science:

• Pharmacology
• Veterinary Medicine
• Neuroscience

Background:

• Benzodiazepines, such as clonazepam, are widely used for their anxiolytic and sedative properties.
• Understanding the potential for physical dependence and withdrawal syndromes is crucial for safe clinical use in veterinary medicine.

Purpose of the Study:

• To investigate the development of physical dependence and withdrawal symptoms in dogs following chronic oral administration of clonazepam.
• To characterize the nature and duration of the abstinence syndrome induced by clonazepam withdrawal in a canine model.

Main Methods:

• Six healthy dogs received oral clonazepam (0.5 mg/kg twice daily) for seven weeks under controlled environmental conditions.
• Flumazepil (Ro 15-1788) was administered intravenously after one week of treatment to assess for early signs of withdrawal.
• Behavioral and physiological parameters were monitored throughout the treatment and withdrawal phases.

Main Results:

• Intravenous flumazepil administration after one week of clonazepam treatment elicited mild withdrawal symptoms.
• Upon cessation of clonazepam, all dogs exhibited a self-limiting abstinence syndrome.
• Observed withdrawal signs included listlessness, 'wet dog shakes,' dorsal recumbency, tremor, hyperthermia, weight loss, and one seizure.
• The abstinence syndrome peaked on days 2-3 post-withdrawal and resolved within one week.

Conclusions:

• Chronic clonazepam administration in dogs can induce physical dependence, detectable even after short-term treatment.
• The observed withdrawal syndrome is transient and self-limiting, resolving within a week of drug cessation.
• This study highlights the importance of considering benzodiazepine withdrawal in veterinary patients.